Jan 9, 2020eFFECTOR Enters Into Agreement with Pfizer Inc. to Develop Novel First-in-Class Inhibitors of eIF4E SAN DIEGO, Jan. 09, 2020 (GLOBE NEWSWIRE) — eFFECTOR Therapeutics, Inc., a leader in the development of selective translation regulators...
Jan 9, 2020Omniome Closes $60 Million Series C Financing to Advance Novel Genomic Sequencing PlatformCompany Raises $145 Million in Eighteen Months to Complete Development and Early Commercialization of Breakthrough DNA Sequencing...
Jan 6, 2020Indigo closes $200M financing to support continued growth of its platforms, including Indigo Grain MIndigo raises an additional $200M, comprised of $175M in convertible equity and $25M in debt, bringing its total capital raised to...